KRISTIE CALLAHAN: Open Payments
NPI 1093129231 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,444 in 122 payments from 26 companies in 2025. Trend: 2023 $2,328 · 2024 $2,265 · 2025 $2,444
Food & beverage: $2,367Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $275 |
| ARGENX US, INC. | 8 | $197 |
| Novartis Pharmaceuticals Corporation | 12 | $191 |
| ANI Pharmaceuticals, Inc. | 11 | $172 |
| PFIZER INC. | 10 | $154 |
| Biogen, Inc. | 7 | $153 |
| Boston Scientific Corporation | 2 | $142 |
| Mallinckrodt Hospital Products Inc. | 3 | $126 |
| ACADIA Pharmaceuticals Inc | 5 | $121 |
| SK Life Science, Inc. | 5 | $115 |
Products named: VYVGART HYTRULO, KESIMPTA, PURIFIED CORTROPHIN GEL, WATCHMAN Access System, ACTHAR, NUPLAZID, NURTEC ODT, UBRELVY.
Industry payments across MS — which companies pay providers there.
